News

BioEurope

Our CEO, Owe Orwar, and CSO, Carolina Trkulja, will be attending BioEurope in Copenhagen, 5-7 November, 2018

Read more

6 october

Professor Owe Orwar, CEO of Oblique Therapeutics will make the first public disclosure of the company´s transformative platform…

Read more